CHMA
Chiasma, Inc.
Set alert
3.76 0.00 0.00%
3.76 Day range 4.10
52-week range unavailable
- Open
- 4.08
- Prev close
- 3.76
- Mkt cap
- 237.81M
- Vol
- 8.20M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.76
- High
- 4.10
- Forward P/E
- -5.30
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2021
- 50-d avg
- 4.35
- 200-d avg
- 3.86
- 1y target
- 0.00
Key statistics
- Market cap
- 237.81M
- Trailing P/E
- 0.00
- Forward P/E
- -5.30
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 4.35
- 200-day average
- 3.86
Analyst view
Consensus: buy
Buy
Price target (mean) 0.00
Ratings (0m) 1 0 buy · 0 hold · 1 sell
- Strong buy0
- Buy0
- Hold0
- Sell1
- Strong sell0
Next earnings
Aug 9, 2021
Expected Aug 9, 2021. Consensus EPS estimate 0.00.
Financials — quick view
CHMA Revenue — quarterly 1.92M
CHMA Net income — quarterly -30.55M
CHMA EPS — quarterly -0.49
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 9, 2021 | Jun 1, 2021 | -0.32 | — | — | — |
| May 5, 2021 | Mar 1, 2021 | -0.30 | — | — | — |
| Mar 4, 2021 | Dec 1, 2020 | -0.35 | — | — | — |
| Nov 5, 2020 | Sep 1, 2020 | -0.41 | — | — | — |
| Aug 10, 2020 | Jun 1, 2020 | -0.40 | — | — | — |
| May 7, 2020 | Mar 1, 2020 | -0.31 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 2020 | Jefferies | init | — | Buy |
| Aug 12, 2020 | HC Wainwright & Co. | main | — | Buy |
| Jun 29, 2020 | HC Wainwright & Co. | main | — | Buy |
| Mar 17, 2020 | HC Wainwright & Co. | main | — | Buy |
| Jul 31, 2019 | Piper Jaffray | init | — | Overweight |
| Mar 7, 2019 | Cantor Fitzgerald | init | — | Overweight |
News
- Amryt Pharma completes Chiasma acquisition
- INVESTIGATION ALERT: Halper Sadeh LLP Investigates ONEM, SYKE, NETE, CHMA, SOLY, ARPO; Shareholders are Encouraged to Contact the Firm
- Chiasma Files Mycapssa European Application For Acromegaly
- Chiasma Announces Submission of Marketing Authorization Application for MYCAPSSA® to the European Medicines Agency
- Chiasma's Mycapssa Associated With Positive Patient-Reported Outcomes In Acromegaly Patients
- Chiasma Presents Positive Patient-Reported Outcomes Data from its MPOWERED™ Phase 3 Trial Comparing MYCAPSSA® to Long-Acting Injectables for the Maintenance Treatment of Adults with Acromegaly
- Chiasma to Present Encore and New Data from MPOWERED™ Phase 3 Trial at Upcoming e-ECE and AACE Virtual Conferences
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates UFS, FOE, CHMA, ACST; Shareholders are Encouraged to Contact the Firm
- Chiasma (CHMA) is Overbought: Is A Drop Coming?
- Amryt Pharma plc (AMYT) Amryt Pharma Acquisition of Chiasma Inc. and Q1 2021 Earnings Conference (Transcript)
Your note
Sign in to keep a note on CHMA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| 7-MED HEALTH VENTURES, L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jul 20, 2015 | 0 |
| FITZPATRICK MARK J | President | Conversion of Exercise of derivative security | Dec 3, 2020 | 19,612 |
| KANNAN RAJ | Chief Executive Officer | Purchase | Nov 22, 2020 | 137,095 |
| LUDLAM WILLIAM | Officer | Purchase | Sep 26, 2019 | 11,799 |
| MAMLUK RONI | Director | Sale | Feb 8, 2021 | 0 |
| MINICK SCOTT | Director | Purchase | Aug 19, 2019 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| MPM Asset Management, LLC | 9.91% | 5,736,296 | 17.95M | Mar 30, 2021 |
| Stonepine Capital Management, LLC | 8.53% | 4,940,273 | 15.46M | Mar 30, 2021 |
| Blackrock Inc. | 7.44% | 4,307,210 | 13.48M | Mar 30, 2021 |
| Eventide Asset Management LLC | 5.18% | 3,000,326 | 9.39M | Mar 30, 2021 |
| Vanguard Group, Inc. (The) | 4.97% | 2,877,947 | 9.01M | Mar 30, 2021 |
| Rock Springs Capital Management, LP | 3.76% | 2,174,583 | 6.81M | Mar 30, 2021 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund | 5.18% | 3,000,326 | 9.39M | Mar 30, 2021 |
| Vanguard Total Stock Market Index Fund | 3.08% | 1,783,896 | 5.58M | Mar 30, 2021 |
| Bruce & Co., Inc. | 2.16% | 1,250,100 | 5.91M | Jun 29, 2021 |
| Vanguard Extended Market Index Fund | 1.23% | 710,839 | 2.22M | Mar 30, 2021 |
| Fidelity Small Cap Index Fund | 0.62% | 358,798 | 1.07M | Apr 29, 2021 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.56% | 325,000 | 1.02M | Mar 30, 2021 |